Thus, in 2022 just 12 clinical studies per one million Romanians were conducted, while the EU’s leader, Denmark, had a 10 higher rate. The data was presented in an analysis conducted by ASEBUSS in partnership with the Romanian Society of Clinical Research Sites (SCRS).
Since 2022, the number of clinical studies in Romania has risen, even tripled. However, this has not been enough for Romania to climb in the ranking, as Poland and Czechia continued to develop this market.
The clinical studies market is expected to reach EUR150 million in Romania in 2026, in line with Health Innovation Hub.
(English version by Catalina Apostoiu)